In The News Posted August 23, 2019 Share Posted August 23, 2019 ZUG, Switzerland, Aug. 23, 2019 /PRNewswire/ -- Aevolve, a medical innovation platform, today announced that it will be making support for rare disease research a top priority in its blockchain-powered accelerator, which provides a pathway for alternative funding of medical innovations... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.